Immunic Inc
IMUX0.845USD
+0.005+0.60%
收盘 09/19, 16:00（美东）报价延迟15分钟
83.36M总市值
亏损市盈率 TTM
关于 Immunic Inc 公司
Immunic, Inc. 是一家生物技术公司。该公司专注于开发用于治疗慢性炎症和自身免疫性疾病的口服小分子疗法的临床产品线。该公司的主导开发项目 vidofludimus calcium (IMU-838) 分别处于治疗复发性和进行性多发性硬化症的 III 期和 II 期临床试验阶段，并在 II 期临床试验中显示出对复发缓解型多发性硬化症、进行性多发性硬化症和中度至重度溃疡性结肠炎患者的治疗效果。IMU-856 靶向蛋白质 Sirtuin 6 (SIRT6)，旨在恢复肠道屏障功能并再生肠道上皮，这可能适用于多种胃肠道疾病，例如乳糜泻。IMU-381 处于临床前测试阶段，这是一种正在开发的下一代分子，专门用于满足胃肠道疾病的需求。
公司简介
公司代码IMUX
公司名称Immunic Inc
上市日期Apr 17, 2014
CEODr. Daniel Vitt, Ph.D.
员工数量91
证券类型Ordinary Share
年结日Apr 17
公司地址1200 Avenue Of The Americas
城市NEW YORK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编10036
电话13322559818
网址https://imux.com/
公司代码IMUX
上市日期Apr 17, 2014
CEODr. Daniel Vitt, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Vitt, Ph.D.
Dr. Daniel Vitt, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
391.88K
+3.98%
Dr. Joerg Neermann, Ph.D.
Dr. Joerg Neermann, Ph.D.
Independent Director
Independent Director
200.00K
+100.00%
Mr. Glenn Whaley, CPA
Mr. Glenn Whaley, CPA
Chief Financial Officer
Chief Financial Officer
95.51K
+89.09%
Dr. Duane D. Nash, M.D.
Dr. Duane D. Nash, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
42.03K
+90.78%
Mr. Jason Tardio
Mr. Jason Tardio
President, Chief Operating Officer
President, Chief Operating Officer
12.51K
--
Ms. Simona Skerjanec, M.D.
Ms. Simona Skerjanec, M.D.
Independent Director
Independent Director
--
--
Dr. Andreas Muehler, M.D.
Dr. Andreas Muehler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Inderpal Singh
Mr. Inderpal Singh
General Counsel
General Counsel
--
--
Ms. Maria Toernsen
Ms. Maria Toernsen
Independent Director
Independent Director
--
--
Dr. Hella Kohlhof, Ph.D.
Dr. Hella Kohlhof, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Vitt, Ph.D.
Dr. Daniel Vitt, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
391.88K
+3.98%
Dr. Joerg Neermann, Ph.D.
Dr. Joerg Neermann, Ph.D.
Independent Director
Independent Director
200.00K
+100.00%
Mr. Glenn Whaley, CPA
Mr. Glenn Whaley, CPA
Chief Financial Officer
Chief Financial Officer
95.51K
+89.09%
Dr. Duane D. Nash, M.D.
Dr. Duane D. Nash, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
42.03K
+90.78%
Mr. Jason Tardio
Mr. Jason Tardio
President, Chief Operating Officer
President, Chief Operating Officer
12.51K
--
Ms. Simona Skerjanec, M.D.
Ms. Simona Skerjanec, M.D.
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月25日 周一
更新时间: 8月25日 周一
持股股东
股东类型
持股股东
持股股东
占比
abrdn Inc.
8.36%
BVF Partners L.P.
7.76%
Soleus Capital Management, L.P.
7.39%
Avidity Partners Management LP
5.69%
The Vanguard Group, Inc.
4.18%
其他
66.62%
持股股东
持股股东
占比
abrdn Inc.
8.36%
BVF Partners L.P.
7.76%
Soleus Capital Management, L.P.
7.39%
Avidity Partners Management LP
5.69%
The Vanguard Group, Inc.
4.18%
其他
66.62%
股东类型
持股股东
占比
Hedge Fund
26.73%
Investment Advisor
12.31%
Investment Advisor/Hedge Fund
10.74%
Research Firm
3.75%
Individual Investor
1.32%
Pension Fund
0.03%
Bank and Trust
0.02%
其他
45.09%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
135
50.98M
53.18%
-8.45M
2025Q1
143
43.91M
45.87%
-16.90M
2024Q4
141
54.47M
60.46%
-15.06M
2024Q3
152
61.42M
68.19%
-8.79M
2024Q2
169
63.34M
74.84%
-9.30M
2024Q1
202
64.86M
76.52%
-3.93M
2023Q4
199
22.30M
46.89%
-13.27M
2023Q3
205
25.26M
53.96%
-11.93M
2023Q2
209
27.09M
58.47%
-12.08M
2023Q1
208
31.66M
68.86%
-6.82M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
abrdn Inc.
1.06M
1.11%
+1.06M
--
Mar 31, 2025
BVF Partners L.P.
8.90M
9.29%
--
--
Mar 31, 2025
Soleus Capital Management, L.P.
7.29M
7.61%
--
--
Mar 31, 2025
Avidity Partners Management LP
4.45M
4.65%
-3.51M
-44.09%
Mar 31, 2025
The Vanguard Group, Inc.
3.93M
4.1%
+7.79K
+0.20%
Mar 31, 2025
Morgan Stanley & Co. LLC
532.36K
0.56%
-535.90K
-50.17%
Mar 31, 2025
Focus Partners Wealth, LLC
2.58M
2.7%
+415.10K
+19.14%
Mar 31, 2025
Gratus Capital LLC
2.11M
2.2%
+56.86K
+2.77%
Jun 30, 2024
Omega Fund Management, LLC
1.79M
1.87%
--
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
